B-cell frequencies and immunoregulatory phenotypes in myeloproliferative neoplasms: influence of ruxolitinib, interferon-α2, or combination treatment

A L Sørensen, M E Bjørn, C H Riley, M Holmstrøm, M H Andersen, I M Svane, S U Mikkelsen, V Skov, L Kjaer, H C Hasselbalch, C H Nielsen

6 Citations (Scopus)

Fingerprint

Dive into the research topics of 'B-cell frequencies and immunoregulatory phenotypes in myeloproliferative neoplasms: influence of ruxolitinib, interferon-α2, or combination treatment'. Together they form a unique fingerprint.

Medicine & Life Sciences